BridgeBio: Strong Commercial Momentum for Attruby Sets the Stage for Long-Term Profitability
BridgeBio possesses a medium revenue cyclicality rating, and its operating leverage has a low rating. We assess the company's balance sheet as weak due to management's dependence on debt issuance to ...
StanChart shares hit near decade peak after profit rise, $1.5 bln buyback
Standard Chartered announced a new $1.5 billion share buyback on Friday after reporting its annual profit rose 18% on record growth in its wealth business and a strong performance of its markets ...
StanChart reports 18% rise in annual profit, roughly in line with estimates
Standard Chartered reported on Friday its annual profit rose 18%, roughly in line with analysts' estimates, on strong performance of its wealth and markets business.